IDNAvsIJH
iShares Genomics Immunology and Healthcare ETF against iShares Core S&P Mid-Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDNA | IJH | |
|---|---|---|
| Expense ratio | 0.47% | 0.050% |
| Assets | $340M | $123.7B |
| Net flow, 1 month | +$36M | +$109M |
| Net flow, 1 year | +$138M | +$10.7B |
| Return, YTD | +49.9% | +10.2% |
| Return, 1 year | — | — |
| Avg daily volume | 163K | 8.1M |
| Holdings | 50 | 408 |
| Listed | Jun 11, 2019 | May 22, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS